Refractory fallopian tube carcinoma Clinical Trials
Conditions / Refractory fallopian tube carcinoma
Delta Trials indexes 8 clinical trials for Refractory fallopian tube carcinoma in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 2 trials have reached completion. This research takes place spanning 9 research sites around the world. An additional 4 trials are in preparatory or other active non-recruiting stages. Since 2020, 3 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
8
Total Trials
2
Recruiting
2
Completed
4
Other Active
3
Terminated since 2020
9
Study Locations
Browse by location (9 total)
- Houston, United States 2 trialsAll trials in Houston, United States
- Detroit, United States 1 trialAll trials in Detroit, United States
- Seattle, United States 1 trialAll trials in Seattle, United States
- Scottsdale, United States 1 trialAll trials in Scottsdale, United States
- Chicago, United States 1 trialAll trials in Chicago, United States
- Buffalo, United States 1 trialAll trials in Buffalo, United States
- Flint, United States 1 trialAll trials in Flint, United States
- Rochester, United States 1 trialAll trials in Rochester, United States
- Bethesda, United States 1 trialAll trials in Bethesda, United States